The PGA Tour has suspended Trey Mullinax for violating the Tour’s anti-doping policy, it announced Wednesday.
Mullinax tested positive for performance-enhancing substances that are prohibited by the World Anti-Doping Agency. Mullinax has accepted his suspension, which will conclude Jan. 16, 2027.
“To my fans, I want to address the news regarding my failed anti-doping test and the suspension that followed,” Mullinax said in a statement provided by the Tour. “I take full responsibility for what happened. At the end of the day, it is my responsibility to understand and follow the PGA Tour’s Anti-Doping Policy and all of its rules and regulations. I failed to do that, and that is on me. I recently used a medication to treat a condition I was originally diagnosed with in college without seeking approval under the Tour’s Anti-Doping Policy.
“My lack of knowledge is not an excuse. It was my responsibility to know the rules before taking any medication and I failed to do so. I want to be absolutely clear: I have never taken any substance with the intention of gaining a competitive advantage. Anyone who knows me knows how much I respect this game and the values it represents.
“I accept the consequences of my actions and will use this experience as a lesson. Golf has given me so much, and I never want one mistake to define the respect I have for the game or for the people who support me. Thank you to everyone who has supported me, and I look forward to competing again in 2027.”
Mullinax, who has one PGA Tour win at the 2022 Barbasol Championship, has made only two PGA Tour starts this year, missing the cut at the Texas Children’s Houston Open and the Zurich Classic of New Orleans.
Cameron Jourdan is an assistant editor of Golfweek, covering college and amateur golf, the PGA Tour and plenty more. Follow Cameron on X/Twitter (@Cam_Jourdan) or Instagram (@GolfweekJourdan).